Project

EORTC 1901-LCG PRIMALung Study

Scheduled ยท 2022 until 2030

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Scheduled
Start Date
2022
End Date
2030
Financing
Others
Study Design
This is an academic-led, open-label, multicentre, randomized phase III trial.
Brief description/objective

PRophylactic cerebral Irradiation or active MAgnetic resonance imaging surveillance in small-cell Lung cancer patients (PRIMALung study)